Company Filing History:
1 out of 134 
1 out of 3,687 
1 out of 8 Years Active: 2024
Title: Lucie Jelinkova: Pioneer in Malaria Immunogen Research
Introduction
Lucie Jelinkova is an innovative inventor based in Albuquerque, NM, known for her significant contributions to the field of immunology. Her groundbreaking work has led to the development of a notable patent aimed at combating malaria, a disease that poses a serious health threat worldwide.
Latest Patents
Jelinkova holds a patent for a "Malaria immunogen and methods for using same." This patent describes an immunogen that includes an immunogenic carrier and an antigenic malaria circumsporozoite protein (CSP) peptide. Specifically, the patented immunogen incorporates the peptide NANPNVDPNANPNVD (SEQ ID NO:2) linked to the immunogenic carrier. This innovative immunogen can be administered to individuals who are at risk of contracting malaria or experiencing blood-stage parasitemia. Furthermore, it may also be used in conjunction with other therapeutic agents for enhanced treatment of the disease.
Career Highlights
Throughout her career, Jelinkova has collaborated with esteemed organizations such as UNM Rainforest Innovations and The Johns Hopkins University. Her work not only reflects her expertise but also underscores her dedication to advancing medical science through innovative solutions.
Collaborations
In her professional journey, Jelinkova has worked alongside notable colleagues, including Bryce Chackerian and Fidel P Zavala. These collaborations have played a crucial role in her research, facilitating the exchange of ideas and expertise necessary for groundbreaking discoveries in the treatment of malaria.
Conclusion
Lucie Jelinkova's contributions to malaria research exemplify the importance of innovation in addressing global health challenges. Her patent serves as a testament to her dedication and skill as an inventor, paving the way for potential treatments that could save countless lives. As she continues her work, the impact of her innovations will be closely watched within the scientific community and beyond.